We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Antibodies – Products

3D rendering of antibody-drug conjugates (ADCs) in a blue molecular environment, showcasing complex antibody structures.
App Note / Case Study

Streamlining the Analysis of Free Drug Content in ADCs

This application note presents a method that integrates protein elimination and free drug identification into one analysis using a two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry (2D-LC/Q-TOF) approach.
Antibodies.
Product News

Evotec Receives Grant From Korean Government To Develop Novel Antibody-Based Treatments for Lung Diseases

Evotec SE announced that, together with Yonsei University and the Korean biotech company Zymedi, it will receive a US$ 4.5m grant from the Korea Institute of Advanced Technology (KIAT).
3D illustration of antibodies floating near a virus particle against a blue background, symbolizing immune response and antibody interaction with pathogens.
Whitepaper

Streamlining Antibody Therapeutic Purification With a Novel Approach

This whitepaper explores novel affinity capture technologies, which offer a powerful solution for purifying complex antibody formats with greater efficiency and higher yields.
A screenshot from the software.
Product News

Refeyn Launches Software Platform To Automate Mass Photometry Analysis Workflows

Refeyn, has developed and launched a custom software platform providing automated analysis of large mass photometry data sets.
3D rendering of an antibody structure on a blue background, representing immunology and protein research
App Note / Case Study

Complementary Methodologies To Optimize Monoclonal Antibody Analysis

This application note explores how these complementary techniques provide unique insights into size heterogeneity, offering a clearer picture of antibody integrity.
Antibodies.
Product News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

BioPharmaSpec has officially announced three new European facilities. The new facilities will focus on discovery and R&D services, offering structural and physicochemical characterization services for a wide variety of biopharmaceutical products.
A vial containing a DNA molecule held up.
Product News

Lonza Extends Collaboration With Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates

Lonza, announced a long-term extension of its collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs.
Sample loading on a Refeyn Mass Photometer.
Product News

Refeyn Establishes New Mass Photometry Scientific Advisory Board To Maximize Potential of Transformative Technology

Refeyn, announces that it has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, Oxford University and co-founder of Refeyn.
Therapeutic Protein Development, Protein Expression System, Gene Expression Technology, Biopharmaceutical Manufacturing, Protein Discovery to Commercialization, Therapeutic Protein Production, Gene Expression for Biologics, Bioprocessing Solutions, GS Gene Expression System, Protein Therapeutics, Commercial-Scale Protein Production, Protein Expression Platform, Biopharma Gene Expression, High-Yield Protein Production, Biotherapeutic Development
Product
Advertisement

GS Gene Expression System®: Taking Your Therapeutic Protein from Discovery to Commercial

Lonza’s GS Gene Expression System® is a comprehensive toolbox for therapeutic protein expression, supporting the production of various molecules, including monoclonal antibodies, bispecifics, fusion proteins and beyond, with titres up to 9 g/L.
Floating orange and red antibody
Whitepaper

Emerging Technological Landscapes in Biomanufacturing and Monoclonal Antibody Screening

Scientists are constantly innovating newer technologies that allow them to understand nuances within these drugs and find ways to manufacture them more reliably.
Advertisement